NCT04541706 Lorlatinib in ALK Inhibitor Treated Unresectable Advanced/Recurrent ALK-Positive Non Small Cell Lung Cancer Patients in India Status COMPLETED Phase PHASE4
NCT04535349 Quantitative Analysis of Myocardial Uptake of Bone Radiopharmaceuticals in Patients With Cardiac ATTR Amyloidosis Status RECRUITING Phase NA
NCT04535167 First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19. Status COMPLETED Phase PHASE1
NCT04530838 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants Status COMPLETED Phase PHASE3
NCT04526574 Safety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults ≥65 Years of Age Status COMPLETED Phase PHASE3
NCT04517864 PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA Status TERMINATED Phase PHASE2
NCT04517669 Effectiveness of Treatment With Tofacitinib in Patients With Psoriatic Arthritis in Routine Clinical Practice Status COMPLETED Phase N/A
NCT04511533 Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations Status COMPLETED Phase PHASE4
NCT04511039 Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer Status RECRUITING Phase PHASE1
NCT04507776 Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel Status COMPLETED Phase N/A
NCT04507763 Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis Status COMPLETED Phase N/A
NCT04505410 Second Line Induction Therapy and Healthy Diet for Patients With Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT04504201 Patient-centered Communication About Healthy Weight in Early Breast Cancer Status COMPLETED Phase N/A
NCT04498520 Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer Status WITHDRAWN Phase PHASE1
NCT04498481 TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING. Status COMPLETED Phase N/A
NCT04498403 A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic Dermatitis Status TERMINATED Phase PHASE3
NCT04495140 Study To Characterize Mass Balance, Absolute Bioavailability, Fraction Absorbed And Pharmacokinetics Of 14C PF-06882961 Status COMPLETED Phase PHASE1